.-Different signals with key roles in energy homeostasis regulate the reproductive axis. These include neuropeptide Y and polypeptide YY3-36, whose type Y2 receptor is the most abundant of this family in the brain. We evaluated herein the putative roles of Y2 receptors in the control of gonadotropin secretion by means of central administration of PYY (agonist of Y2 receptors) and BIIE 0246 (antagonist of Y2 receptors) to intact and orchidectomized male rats. In addition, the ability of PYY13-36 to elicit GnRH and gonadotropin secretion in vitro and the impact of fasting on LH responses to PYY13-36 in vivo were also monitored. Central administration of PYY13-36 significantly decreased the circulating levels of both gonadotropins, an effect that was observed in prepubertal and adult rats. Yet a dual action of Y2 receptors in the control of male gonadotropic axis was evidenced as their activation induced 1) stimulation of gonadotropin responses to GnRH at the pituitary but 2) inhibition of GnRH secretion at the hypothalamus. Antagonization of Y2 receptors failed to modify basal LH secretion in intact males either after being fed ad libitum or after being fasted. In contrast, their central blockade in orchidectomized rats evoked a significant increase in circulating LH and FSH level, suggesting the constitutive activation of Y2 receptor in such stimulated conditions. In summary, our data evidence a complex mode of action of Y2 receptors in the control of gonadotropic axis, with stimulatory and inhibitory actions at different levels of the system that are sensitive to the gonadal status. polypeptide YY3-36; luteinizing hormone-releasing hormone; luteinizing hormone; follicle-stimulating hormone; fasting; pituitary IT IS KNOWN THAT THE INITIATION OF PUBERTY and the integrity of reproductive function are physiologically coupled to nutritional status. A large body of evidence accumulated over the last several years (14, 23, 24, 40, 42) indicates that feeding behavior and activity of the gonadotropic axis are linked and that the pancreatic polypeptide family may be pivotal in this relationship. The pancreatic polypeptide family consists of a series of related peptides composed of 36 amino acids termed neuropeptide Y (NPY) 1-36 , peptide YY (PYY) , and pancreatic peptide (PP) 1-36 (47). NPY is located predominantly within neurons of the central and sympathetic nervous systems (1, 10, 28); PYY (70% similar to NPY) is secreted by the gastrointestinal tract and is converted into the PYY 3-36 form by the enzyme dipeptidyl peptidase IV, which is widely distributed in numerous tissues and in plasma (17); and finally, PP is secreted by cells within the endocrine and exocrine pancreas. All of these peptides carry out diverse biological actions through interaction with different receptor subtypes, namely Y receptors, that are members of the seven-transmembrane domain G protein-coupled receptors associated with inhibition of adenylate cyclase.
IT IS KNOWN THAT THE INITIATION OF PUBERTY and the integrity of reproductive function are physiologically coupled to nutritional status. A large body of evidence accumulated over the last several years (14, 23, 24, 40, 42) indicates that feeding behavior and activity of the gonadotropic axis are linked and that the pancreatic polypeptide family may be pivotal in this relationship. The pancreatic polypeptide family consists of a series of related peptides composed of 36 amino acids termed neuropeptide Y (NPY) , peptide YY (PYY) , and pancreatic peptide (PP) (47) . NPY is located predominantly within neurons of the central and sympathetic nervous systems (1, 10, 28) ; PYY (70% similar to NPY) is secreted by the gastrointestinal tract and is converted into the PYY form by the enzyme dipeptidyl peptidase IV, which is widely distributed in numerous tissues and in plasma (17) ; and finally, PP is secreted by cells within the endocrine and exocrine pancreas. All of these peptides carry out diverse biological actions through interaction with different receptor subtypes, namely Y receptors, that are members of the seven-transmembrane domain G protein-coupled receptors associated with inhibition of adenylate cyclase.
In both humans and rats, five Y receptor subtypes (Y 1 -Y 5 ) have been characterized on the basis of different pharmacological profiles and/or cloning (6, 15, 31) . The Y 1 receptor subtype requires the full molecule of NPY and PYY for its activation and is selectively activated by [Leu 31 ,Pro 34 ] homologues, although it has lower affinity for COOH-terminal fragments such as NPY and PYY (10) . The Y 2 receptor is preferentially activated by COOH-terminal NPY and PYY fragments and is activated to a lower extent by the [Leu 31 ,Pro 34 ] homologues (13) . The Y 3 receptor is preferentially activated by NPY rather than PYY, whereas the Y 4 receptor is activated by PP and PYY but not NPY derivatives (31) . Finally, the Y 5 receptor subtype is activated by PP, NPY, PYY, and PYY (31) . Regarding the location in the brain of different Y receptor subtypes, the Y 2 receptors are the predominant Y receptor subtype in the brain, whereas the Y 4 subtype represents only a very small proportion of the total population of Y receptors. The Y 2 receptor is associated with suppression of the release of transmitters such as glutamate, noradrenalin, and NPY (9, 11, 27, 30) , and it is involved in NPY effects on food intake, gastrointestinal motility, cardiovascular regulation, and neuronal excitability (8, 22, 34) . A number of brain regions contained the Y 5 receptor subtype, including various hypothalamic nuclei, the midline thalamus, parts of the amygdala, the hippocampus, and some midbrain and brain stem nuclei. Together with the Y 1 receptor subtype, the Y 5 receptor has been implicated in mediating the orexigenic effect of NPY and in regulating food intake and body weight (12, 16, 19, 20) .
Although the role of different Y receptor subtypes in the control of food intake was clarified years ago (Y 1 and Y 5 are appetite-stimulating receptors and Y 2 is an appetite-inhibiting receptor) (3, 16, 45) , their participation in the control of reproductive function remained poorly defined, probably because data about the effects of different pancreatic polypeptide family members on the control of the hypothalamic-pituitarygonadal axis are controversial. Thus, for NPY (preferential Y 1 and Y 5 agonist), discrepant stimulatory or inhibitory effects on sexual maturation and reproduction have been observed de-pending upon species, steroid environment (26), the site of NPY administration into the brain (37) , and a chronic (18, 38, 39) vs. acute (32) pattern of infusion. Likewise, PYY (preferential Y 2 and Y 5 agonist) has been reported to be stimulatory or inhibitory or to have no effect on gonadotropinreleasing hormone (GnRH) and gonadotropin secretion depending upon the age, sex, steroidal environment, and in vivo vs. in vitro studies (14, 40, 43) . PP (preferential Y 4 agonist) has been reported to increase or not affect gonadotropin secretion depending upon the species and steroidal environment (21, 43, 44) .
In previous experiments carried out in prepubertal and adult rats (14, 40) we have shown that PYY 3-36 controlled GnRH and gonadotropin secretion, and we demonstrated that its effects are modulated by nutritional status. The expression of the genes encoding Y 2 and Y 5 receptors in the hypothalamus and pituitary (14, 40) opens up the possibility that the described effects of PYY were mediated by Y 2 or Y 5 receptors or the net balance between both of them. To clarify the participation of the Y 2 receptor subtype in the control of gonadotropin secretion, BIIE 0246 (antagonist of Y 2 receptors) and PYY (agonist of Y 2 receptors) were tested, either in vivo or in vitro, in male rats at different ages and with different steroidal background. In addition, since fasting significantly impairs reproductive function (4, 5, 7, 40) , and given that the effects of PYY were potentiated during fasting (40), we also analyzed the actions of PYY and BIIE 0246 in male rats subjected to fasting.
MATERIALS AND METHODS

Animals and Drugs
Male Wistar rats born in our laboratory were kept under controlled conditions of light (12:12-h light-dark cycle, lights on at 0700) and temperature (22°C) with free access to pelleted food (Pacsa Sanders, Sevilla, Spain) and tap water. Experiments were carried out in prepubertal (25 days) and adult animals. NPY (agonist of Y 1, Y2, and Y5 receptors), PYY13-36 (agonist of Y2 receptors), and BIIE 0246 (antagonist of Y2 receptors) were purchased from Bachem (Barcelona, Spain). NPY and PYY13-36 were dissolved in saline or DMEM immediately before use, and BIIE 0246 was dissolved in 15% DMSO.
Experimental Designs
Experimental procedures were approved by the Córdoba University Ethics Committee for animal experimentation and were conducted in accordance with the European Union normative for care and use of experimental animals. The number of animals per experimental group was 10 -14 in the in vivo experiments, and each experimental group consisted of 10 -12 samples in the in vitro studies. Adult animals were used at 90 -110 days of age. Experiments were carried out between 1000 and 1200. Special caution was taken to avoid any stressing influences upon the experimental animals (all of the animals were handled daily for 1 wk before the experiment, they were humanely killed by the same person, and the different drugs were injected at random).
In the initial set of experiments, we analyzed the effects of central injection of PYY on gonadotropin secretion in intact and orchidectomized prepubertal and adult males. We also evaluated the physiological relevance of Y2 receptors. (4, 5, 7, 40 ) that gonadotropin secretion is profoundly depressed after fasting. Since in a previous study (40) we demonstrated that the effects of PYY3-36 on gonadotropin secretion are modulated by fasting, we analyzed the effects of PYY in fasted male rats. Adult males fed ad libitum or submitted to a 4-day period of total food restriction were intracerebroventricularly injected with PYY (0.1, 1, or 3 nmol ⅐ rat Ϫ1 ⅐ 10 l Ϫ1 ) or vehicle through a cannula that was implanted as described above. Blood samples were obtained by jugular venipuncture after light ether anesthesia before and 15, 30, and 60 min after the injections.
Experiment 4: effects of antagonization of Y2 receptors on gonadotropin secretion. Data obtained in previous experiments showed that PYY13-36 induced a significant inhibition of gonadotropin secretion in different experimental conditions. To analyze the functional relevance of this finding, adult male rats fed ad libitum, either orchidectomized or sham orchidectomized 1 wk earlier, and intact males subjected to 4-day fasting were implanted, as described previously, with intracerebroventricular cannulae and injected with BIIE 0246 (5 nmol ⅐ rat Ϫ1 ⅐ 10 l Ϫ1 ) or vehicle. Blood samples were obtained by jugular venipuncture after light ether anesthesia before and 15, 30, and 60 min after the injection. The dose of antagonist was selected on the basis of previous experiments showing that higher doses (10 and 20 nmol/rat) induced similar gonadotropin responses but clear-cut signs of locomotor hyperactivity (our unpublished data).
In addition, the following set of experiments was carried out to analyze the possible targets involved in the inhibitory effect of PYY13-36 (Y2 receptor activation) on gonadotropin secretion.
Experiment 5: effects of activation of Y 2 receptors on GnRH secretion by hypothalamic explants from adult male rats.
To analyze a potential primary action of PYY13-36 upon hypothalamic GnRH secretion, a static incubation system was used. Adult male rats were humanely killed by decapitation, and the hypothalami (excised by a horizontal cut of ϳ2 mm depth with the following limits: 1 mm anterior from the optic chiasm, the posterior border of the mamillary bodies, and the hypothalamic fissures) were rapidly dissected out. Tissue samples were subsequently incubated in 250 l of DMEM in a Dubnoff shaker incubator under an atmosphere of 95% O 2-5% CO2 at 37.5°C. After a 30-min preincubation the medium was removed, and the hypothalami were challenged for 30 min with PYY13-36 (10 Ϫ6 M), 56 nM KCl, or medium alone. At the end of incubation period, medium samples were boiled for 30 min to inactivate endogenous protease activity and were stored at Ϫ80°C until they were used for hormone measurements.
Experiment 6: effects of activation of Y 2 receptors on pituitary basal and GnRH-stimulated gonadotropin secretion.
To analyze a potential primary action of PYY at the pituitary level in the regulation of gonadotropin secretion, adult male rats were humanely killed by decapitation, and the pituitaries were immediately dissected, the posterior lobe was discarded, and the pituitaries were halved. The hemipituitaries were placed in glass scintillation vials (1 hemipituitary/vial) in a Dubnoff shaker at 37°C in an atmosphere of 95% O 2-5% CO2. Each vial contained 1 ml of DMEM. After preincubation for 60 min, the medium was replaced by fresh medium alone or medium containing PYY ( 
Hormone Assays
Serum and medium concentrations of LH and FSH were measured using a double-antibody method and radioimmunoassay kits kindly supplied by the National Institutes of Health (Dr. A. F. Parlow; National Institute of Diabetes and Digestive and Kidney Diseases National Hormone and Peptide Program, Torrance, CA). Rat LH-I-9 and FSH-I-9 were labeled with 125 I using the Iodo-Gen method, following the instructions of the manufacturer (Pierce, Rockford, IL), and hormone concentrations were expressed using LH-RP-3 and FSH-RP-2 as standards. All samples were measured in duplicate, and all samples from each experiment were measured in the same assay. Intra-assay coefficients of variation were Ͻ8%, and the sensitivities of the assays were 20 and 7.5 pg/50 l for LH and FSH, respectively.
GnRH concentrations in the incubation medium were measured in 100-l aliquots using a commercial RIA kit from Peninsula Laboratories (Bachem Group, San Carlos, CA), following the instructions of the manufacturer. The sensitivity of the assay was 1 pg/tube. All samples were measured in the same assay.
Presentation of Data and Statistics
Values are expressed as means Ϯ SE. When appropriate, integrated LH and FSH secretor responses were calculated as the area under the curve, using the trapezoidal rule. Differences between groups were analyzed using the unpaired Student's t-test or ANOVA followed by Student-Newman-Keuls multiple-range test (SigmaStat 2.0; Jandel, San Rafael, CA). P Յ 0.05 was considered significant.
RESULTS
Effects of Central Administration of NPY and PYY 13-36 on Gonadotropin Secretion in Prepubertal Males
In intact and orchidectomized prepubertal male rats, intracerebroventricular administration of NPY significantly stimulated LH and FSH secretion (Fig. 1) . The amplitude of the response of both gonadotropins was similar for the three doses tested; the LH response was greater than the FSH response in intact and orchidectomized animals.
In contrast to NPY, PYY significantly decreased LH secretion in intact and orchidectomized rats (Fig. 2, top) . In addition, PYY significantly lowered serum FSH concentrations in intact males, whereas no effects were observed in orchidectomized animals (Fig. 2, bottom) . 
Effects of Central Administration of PYY 13-36 on Gonadotropin Secretion in Adult Intact and Orchidectomized Males Fed Ad Libitum
In intact adult male rats, intracerebroventricular administration of PYY significantly decreased LH secretion at doses of 1 and 3 nmol (Fig. 3, top) . This effect was evident 15 min after injection and remained significant for Ն60 min. After orchidectomy, the inhibitory effect of PYY on LH secretion was evident only with the 3-nmol dose (Fig. 3, bottom) .
Central intracerebroventricular administration of PYY 13-36 significantly decreased FSH secretion in intact (Fig. 4, top) and orchidectomized males (Fig. 4, bottom) . In intact rats, the effect was statistically significant 15 min after injection of 1 and 3 nmol and remained evident for Ն60 min, whereas only the highest dose was effective in orchidectomized rats.
Effects of Central Administration of PYY 13-36 on Gonadotropin Secretion in Adult Fasted Males
In males submitted to a 4-day fasting period, a significant decrease in body weight was observed (273 Ϯ 4.8 vs. 320 Ϯ
g in controls)
. Serum gonadotropin secretion was reduced in fasted rats (LH: 0.17 Ϯ 0.04 vs. 1.16 Ϯ 0.08 ng/ml in controls; FSH: 5.41 Ϯ 1.0 vs. 9.12 Ϯ 0.63 ng/ml in controls). Administration of PYY induced further reductions in gonadotropin secretion (Fig. 5) , which was more evident for FSH, probably due to the extremely low levels of LH after fasting.
Effects of Central Administration of BIIE 0246 on Gonadotropin Secretion in Adult Fed and Fasted Males
Central intracerebroventricular administration of a single dose of 5 nmol of Y 2 receptor antagonist had no significant effect on circulating LH levels at any of the time points studied either in adult males fed ad libitum or in males after 4-day fasting (Fig. 6, top and bottom) . A lack of effect on FSH was also observed (data not shown). In contrast, the antagonist led to a significant increase in serum LH concentrations 15 and 30 min after injection to orchidectomized animals (Fig. 6, middle) . An increase in FSH secretion was also observed at these time points in orchidectomized animals (data not shown). 
Effects of PYY 13-36 on Hypothalamic GnRH Secretion
The amount of GnRH released by the hypothalami of adult intact males over 30 min significantly increased after depolarization with KCl (28.04 Ϯ 2.07 vs. 22.51 Ϯ 1.47 pg/hypothalamus in controls) and decreased in the presence of 10 Ϫ6 M PYY 13-36 (17.95 Ϯ 1.72 vs. 22.51 Ϯ 1.47 pg/hypothalamus in controls). The statistical analysis indicated that differences between groups were significant (F ϭ 8,14, P Յ 0.002).
Effects of PYY 13-36 on Basal and GnRH-Stimulated Gonadotropin Secretion
Concentrations of LH in the medium after 60 and 120 min of incubation were unaffected by PYY at the doses of 10 Ϫ10 , 10 Ϫ8 , and 10 Ϫ6 M. The concentration of FSH was decreased after 60 min of incubation with PYY at the dose of 10 Ϫ6 M (Fig. 7, top) . GnRH significantly stimulated the release of both gonadotropins, an effect that was potentiated by PYY with all of the doses tested (Fig. 7,  bottom) .
DISCUSSION
During the last decade, our knowledge on the signals involved in the cooperative control of energy balance and reproduction has significantly increased. Leptin, ghrelin, and PYY play an important role in the control of the hypothalamic-pituitary-gonadal axis (2, 14, 40, 48 ). The expression of the genes encoding Y 2 and Y 5 receptors in hypothalamus and pituitary (14, 40) opens the possibility that the described effects of PYY were mediated by Y 2 or Y 5 receptors or Fig. 6 . Serum concentrations of LH (ng/ml) in sham-ORX (top) and ORX (middle) rats fed ad libitum as well as in intact adult males submitted to a 4-day period of total food restriction (bottom) before (0 min) and 15, 30, and 60 min after central icv administration of vehicle or Y2 antagonist (Ant-Y2) BIIE 0246 (5 nmol/rat). In addition to the profiles of mean LH and FSH concentrations in the experimental groups, the integrated secretory responses, expressed as the AUC over the study period (60 min), are shown. Values are expressed as means Ϯ SE (for 11-12 animals/group). **P Յ 0.01 vs. corresponding vehicle-injected group (ANOVA followed by Student-Newman-Keuls multiple-range test). Groups with different superscripted letters are statistically different (ANOVA followed by Student-Newman-Keuls multiple-range test). by the net balance between the effects mediated by each. To clarify this possibility, we took advantage of the use of PYY , a selective Y 2 agonist. Indeed, this peptide analog has been widely used in studies aimed to decipher the roles of Y 2 receptors in different physiological processes, such as arterial vasoconstriction (50), vago-vagal reflex circuitry (8), or exocrine pancreatic secretion (49) . Yet to our knowledge, no studies on the gonadotropic effects of such Y 2 receptor agonists had been reported previously.
The major findings of the present study can be summarized as follows: 1) acute administration of different doses of NPY to intact and orchidectomized prepubertal males stimulated LH and FSH secretion, whereas, in contrast, PYY was inhibitory; 2) PYY 13-36 significantly decreased gonadotropin secretion in intact, orchidectomized, and fasted adult males; 3) tonic activation of Y 2 receptors seems to take place after removal of testicular secretion, when Y 2 receptor antagonization elicits further increases in serum gonadotropins, a phenomenon that is not observed in intact males regardless of their feeding status; and 4) PYY inhibited GnRH release by hypothalamic explants ex vivo but potentiated GnRH-stimulated gonadotropin release directly at the pituitary level.
Data from experiments in prepubertal male rats showed that a single intracerebroventricular injection of NPY significantly enhanced gonadotropin secretion, which suggests the possible involvement of NPY in puberty onset, a role that was previously indicated in females (32, 46) . In contrast, intracerebroventricular administration of PYY (14) or PYY (present data) induced a clear inhibition of LH secretion. Overall, these results are evidence that, in prepubertal males, the inhibitory effect of PYY 3-36 on LH secretion is mediated by activation of Y 2 receptors. In addition, our present data in orchidectomized rats demonstrate that neither testicular inputs nor prevailing LH and FSH levels appear to modify gonadotropin responses to NPY or PYY 13-36 before puberty.
As was the case in prepubertal animals, activation of Y 2 receptors after administration of 3 nmol/rat icv of PYY induced a significant reduction in LH and FSH secretion in adult male rats in a diversity of experimental conditions (intact and in orchidectomized males, as well as in fasted animals). Since previous data showed that PYY 3-36 significantly enhanced gonadotropin secretion in control and fasted adult male rats (40), our present results suggest that such stimulatory effects of PYY were not mediated via Y 2 receptors. In addition, our current data demonstrate that, at the adult age, testicular inputs modulated the inhibitory actions of Y 2 receptor activation as central injection of 1 nmol of PYY to intact males decreased both LH and FSH secretion, whereas it was ineffective in orchidectomized animals.
To analyze the impact of blockade of endogenous Y 2 receptors upon gonadotropin secretion, experiments assessing the effects of central administration of BIIE 0246, a selective Y 2 receptor antagonist, were conducted in adult male rats. The lack of effects on gonadotropin levels observed in intact male rats either fed ad libitum or subjected to fasting suggests that, in these conditions, Y 2 receptors are not constitutively activated. In contrast, after orchidectomy, antagonization of Y 2 receptors further increased LH and FSH secretion. These opposite findings might present evidence that, after removal of testicular inhibitory inputs to GnRH/LH system, endogenous activation of Y 2 receptors takes place as servomechanism to prevent excessive secretion of gonadotropins. Accordingly, in these conditions, blockade of Y 2 receptors resulted in further increases in gonadotropin secretion. Of note, inhibitory roles of Y 2 receptor activation have previously been reported (3, 8, 16, 22, 34, 45) in a wide variety of biological processes such as food intake, gastrointestinal motility, cardiovascular regulation, or neuronal excitability.
Y 2 receptor subtype is the predominant Y receptor in the brain and is also present at the pituitary level (14, 40) . In the present work we have analyzed the possible contribution of hypothalamic and pituitary Y 2 receptors in the suppression of gonadotropin secretion that is induced by central administration of PYY . To this end, the effects of this peptide on , and 10 Ϫ6 M) on basal (top) and gonadotropin-releasing hormone (GnRH)-stimulated (bottom) levels of LH and FSH (ng/ ml) secreted by hemipituitaries obtained from adult males. Values are expressed as means Ϯ SE (for 10 -12 samples/group). **P Յ 0.01 vs. hemipituitaries incubated in absence of PYY3-36 (ANOVA followed by Student-Newman-Keuls test).
GnRH and gonadotropin release were explored using incubations of hypothalamic and pituitary tissue, respectively. Our results demonstrate an inhibitory effect of PYY on GnRH release, which is coincident with data reported previously by our group (14, 40) on the ability of PYY to decrease hypothalamic GnRH secretion in prepubertal and adult male rats, thus suggesting the involvement of Y 2 receptor activation in mediating such action. The inhibition of GnRH release might be directly exerted on GnRH neurons or mediated through blockade of different neurotransmitters such as glutamate, NPY, or noradrenaline, which are well-known stimulatory inputs for GnRH neurons (23, 25, 29, 35, 36, 46) and whose release is inhibited after activation of Y 2 receptors (9, 11, 27, 30) . Admittedly, the mechanism(s) involved in the reduction of GnRH release by PYY needs to be characterized further. Yet, the functional relevance of this phenomenon in the control of the gonadotropic axis by Y 2 receptors is reinforced by the absence of inhibitory effects of PYY on basal LH release directly at the pituitary level. In contrast, GnRH-stimulated gonadotropin responses were potentiated in the presence of PYY , suggesting a complex, dual mode of action of Y 2 receptors in the control of gonadotropin secretion at different levels of the hypothalamic-pituitary unit.
In conclusion, present experiments have demonstrated that activation of Y 2 receptors inhibits gonadotropin secretion in vivo, an action that is apparently not conducted at the pituitary but is rather dependent on changes in GnRH release at the hypothalamus. In addition, our data have also disclosed the divergence in some of the gonadotropic effects of PYY (physiological agonist of Y 2 and Y 5 receptors) and PYY (pharmacological agonist of Y 2 receptors), providing further proof for the complexity of Y receptor-mediated actions in the control of reproductive axis. Finally, our results strongly suggest that constitutive activation of Y 2 receptors is likely to take place after removal of testicular inhibitory inputs on the GnRH/ gonadotropin system, a finding whose physiological relevance as servomechanism for the restrain of gonadotropin (hyper) secretion warrants further investigation.
